The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

Zynex Medical Holdings Inc. (ZYNX.OB) Announces Increased Orders for 2008

 Jul 07, 2008 03:44 PM UTC
Symbol Sentiment Start Return Closed
TM n/a
IFC n/a

Graphic_arrow1 Via StraightStocks:  

Zynex Medical has been a leading provider of relief for patients with functional disability through the creation, distribution and marketing of electrotherapy products. Utilizing various methods of non-invasive muscle stimulation and state-of-the-art electromyography technology, Interferential Current (IFC) and Transcutaneous Electrical Nerve Stimulation (TENS), Zynex Medical offers patients a new lease on life by increasing mobility and providing independence.


Zynex Medical also has a product for stroke victims, called NeuroMove, it is designed to increase functionality among stroke victims by teaching the healthy parts of the brain to compensate for the injured areas. NeuroMove(TM) monitors muscle activity and selects signals from the brain indicating that the patient is attempting to move a certain muscle. It then allows the particular muscle to move through electrical stimulation. Many times, the connection between the brain and muscle is restored.


The techniques offered by the company are relatively new for some applications, like fibromyalgia, and can be especially helpful to those who suffer chronically from that type of condition. The fact that Zynex has had increasing orders, not just this quarter, but consistently, speaks to the quality of their product, its ease of use, and the success that existing patients are having with it. This can only bode well for them in the future, as long as Zynex can keep up with demand with the same quality and service they currently provide.


Let us hear your thoughts below:





 Graphic_website1 Read the rest of original post »



Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch